<?xml version="1.0" encoding="UTF-8"?>
<p>In addition, the US has been operating a vaccine effectiveness surveillance [
 <xref rid="B18" ref-type="bibr">18</xref>]. Surveillance for monitoring influenza vaccine effectiveness is managed separately by the US Flu VE Network, which focuses on outpatients, and the US Hospitalized Influenza Vaccine Effectiveness Network, which focuses on inpatients. Each network consists of five sites in the US. At the participating sites, respiratory specimens are collected for isolating influenza viruses together with demographic and medical information, including underlying diseases and influenza vaccination history. The two networks assess and report influenza vaccine effectiveness separately during each season [
 <xref rid="B19" ref-type="bibr">19</xref>
 <xref rid="B20" ref-type="bibr">20</xref>]. The US CDC calculates and reports the influenza disease burden using the Influenza surveillance data, and the averted burden by vaccine based on the surveillance and estimated data [
 <xref rid="B21" ref-type="bibr">21</xref>].
</p>
